NX-5948 5 mg | ≥98% Cayman Chemical A PROTAC that drives BTK degradation More Information Supplier Page × NX-5948
NX-5948 25 mg | ≥98% Cayman Chemical A PROTAC that drives BTK degradation More Information Supplier Page × NX-5948
NX-5948 10 mg | ≥98% Cayman Chemical A PROTAC that drives BTK degradation More Information Supplier Page × NX-5948
NX-5948 1 mg | ≥98% Cayman Chemical A PROTAC that drives BTK degradation More Information Supplier Page × NX-5948
SCH 563705 25 mg | ≥98% Cayman Chemical A CXCR1 and CXCR2 antagonist More Information Supplier Page × SCH 563705
SCH 563705 5 mg | ≥98% Cayman Chemical A CXCR1 and CXCR2 antagonist More Information Supplier Page × SCH 563705
ACY-957 (hydrochloride) 5 mg | ≥98% Cayman Chemical An inhibitor of HDAC1 and HDAC2 More Information Supplier Page × ACY-957 (hydrochloride)
SCH 563705 1 mg | ≥98% Cayman Chemical A CXCR1 and CXCR2 antagonist More Information Supplier Page × SCH 563705
SCH 563705 10 mg | ≥98% Cayman Chemical A CXCR1 and CXCR2 antagonist More Information Supplier Page × SCH 563705
ANR 94 50 mg | ≥98% Cayman Chemical An adenosine A2A receptor antagonist More Information Supplier Page × ANR 94
